Global Acne Medication Market

Acne Medication Comprehensive Study by Type (Injection, Oral), Application (Hospital, Clinic) Players and Region - Global Market Outlook to 2028

Acne Medication Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 4.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Acne Medication Market Scope
Acne also called as acne vulgaris, is a long-term skin disease that arises when hair follicles are blocked with dead skin cells and oil from the skin. Acne presence is considered by blackheads, whiteheads, pimples, oily skin, and possible scarring. Acne appearance can lead to anxiety and reduced self-esteem. Acne medications are drugs that are specified for the treatment of acne. Acne medication include several counter medicines such as retinoid, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, oral contraceptives and many more. Numerous factors such as fluctuating hormone levels, unhygienic lifestyle and excessive production of oil from sebaceous glands have increased the prevalence of acne, thereby driving the market growth. Though products are considered safe, in past FDA has released causes for concerns regarding acne products containing the active ingredients benzoyl peroxide or salicylic acid which could cause rare but serious life-threatening allergic reactions for long duration. Other symptoms of acne medication can be counted as shortness of breath, wheezing, and low blood pressure, and swelling of eyes, face, and lips. Therefore, safety issues regarding these products and availability of substitutes like laser treatment are expected to hamper the growth of acne medication market.

According to AMA, the Global Acne Medication market is expected to see growth rate of 4.1%

Key players are adopting numerous strategy to gain market attention and to increase their market share, this strategy can be listed as increasing product portfolio, making partnership to adopt certain technologies and acquiring small players to finish competition in the future.

Allergan plc (Ireland), Galderma S.A. (Switzerland), LG Chem. (South Korea), BohusBioTech AB (Sweden), Imeik Technology Development Co Ltd (China), Bloomage Freda Biopharm Co. LTD (China), Sinclair Pharma Plc (United Kingdom), Merz Pharma GmbH & Co. KGaA (Germany) Sanofi Aventis (France) and Suneva Medical (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Stiefel (United States), Valeant (Canada) and Bayer HealthCare (Germany).

Segmentation Overview
The study have segmented the market of Global Acne Medication market by Type (Injection and Oral), by Application (Hospital and Clinic) and Region with country level break-up.

On the basis of geography, the market of Acne Medication has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Development of effective therapeutics with lesser side effects, Increasing looks consciousness among people and Enhancement in product usefulness

Market Growth Drivers:
Increasing acne problems due to imbalance in diet, insomnia, stress and tension, enhancements in acne medication treatments, Increasing number of patient due cosmetics side effects, Losing natural hydration due to pollution leads to increase in acne problems and Large number skin consciousness people

Restraints:
Side effects like swelling, redness, and irritation and Presence of alternative such as laser treatment

Opportunities:
Continuously Increasing pollution and atmospheric heat, Increasing number of people with hectic lifestyle, Minimizing costs required for the acne treatments and untapped markets in the emerging economies

Market Leaders and their Expansionary Development Strategies
In June 2021, Hims & Hers Health, a direct-to-consumer virtual care company, is set to enhance its skincare services through the acquisition of the teledermatology platform Apostrophe. The financial details of the acquisition remain undisclosed. This move comes shortly after Hims & Hers Health revealed its acquisition of British telehealth company Honest Health, demonstrating its intent to expand further in the United Kingdom and enter the European Union market. Apostrophe specializes in skincare solutions and provides patients with access to topical and oral medications.
In June 2023, Sun Pharma collaborated with renowned television personality and dermatologist Dr. Sandra Lee, popularly known as Dr. Pimple Popper on the TLC network. The purpose of this partnership is to shed light on the significant role of hormones as the underlying cause of skin acne.


Key Target Audience
Manufacturer, Raw material supplier, Distributors/traders/dealers, Channel partners, Industry Association, Governments and investment communities and Research organizations and associations

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • Injection
  • Oral
By Application
  • Hospital
  • Clinic
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing acne problems due to imbalance in diet, insomnia, stress and tension
      • 3.2.2. Enhancements in acne medication treatments
      • 3.2.3. Increasing number of patient due cosmetics side effects
      • 3.2.4. Losing natural hydration due to pollution leads to increase in acne problems
      • 3.2.5. Large number skin consciousness people
    • 3.3. Market Trends
      • 3.3.1. Development of effective therapeutics with lesser side effects
      • 3.3.2. Increasing looks consciousness among people
      • 3.3.3. Enhancement in product usefulness
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Acne Medication, by Type, Application and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Acne Medication (Value)
      • 5.2.1. Global Acne Medication by: Type (Value)
        • 5.2.1.1. Injection
        • 5.2.1.2. Oral
      • 5.2.2. Global Acne Medication by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
      • 5.2.3. Global Acne Medication Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Acne Medication (Price)
      • 5.3.1. Global Acne Medication by: Type (Price)
  • 6. Acne Medication: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergan plc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Galderma S.A. (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. LG Chem. (South Korea)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BohusBioTech AB (Sweden)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Imeik Technology Development Co Ltd (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bloomage Freda Biopharm Co. LTD (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sinclair Pharma Plc (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merz Pharma GmbH & Co. KGaA (Germany) Sanofi Aventis (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Suneva Medical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Acne Medication Sale, by Type, Application and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Acne Medication (Value)
      • 7.2.1. Global Acne Medication by: Type (Value)
        • 7.2.1.1. Injection
        • 7.2.1.2. Oral
      • 7.2.2. Global Acne Medication by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
      • 7.2.3. Global Acne Medication Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Acne Medication (Price)
      • 7.3.1. Global Acne Medication by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Acne Medication: by Type(USD Million)
  • Table 2. Acne Medication Injection , by Region USD Million (2017-2022)
  • Table 3. Acne Medication Oral , by Region USD Million (2017-2022)
  • Table 4. Acne Medication: by Application(USD Million)
  • Table 5. Acne Medication Hospital , by Region USD Million (2017-2022)
  • Table 6. Acne Medication Clinic , by Region USD Million (2017-2022)
  • Table 7. South America Acne Medication, by Country USD Million (2017-2022)
  • Table 8. South America Acne Medication, by Type USD Million (2017-2022)
  • Table 9. South America Acne Medication, by Application USD Million (2017-2022)
  • Table 10. Brazil Acne Medication, by Type USD Million (2017-2022)
  • Table 11. Brazil Acne Medication, by Application USD Million (2017-2022)
  • Table 12. Argentina Acne Medication, by Type USD Million (2017-2022)
  • Table 13. Argentina Acne Medication, by Application USD Million (2017-2022)
  • Table 14. Rest of South America Acne Medication, by Type USD Million (2017-2022)
  • Table 15. Rest of South America Acne Medication, by Application USD Million (2017-2022)
  • Table 16. Asia Pacific Acne Medication, by Country USD Million (2017-2022)
  • Table 17. Asia Pacific Acne Medication, by Type USD Million (2017-2022)
  • Table 18. Asia Pacific Acne Medication, by Application USD Million (2017-2022)
  • Table 19. China Acne Medication, by Type USD Million (2017-2022)
  • Table 20. China Acne Medication, by Application USD Million (2017-2022)
  • Table 21. Japan Acne Medication, by Type USD Million (2017-2022)
  • Table 22. Japan Acne Medication, by Application USD Million (2017-2022)
  • Table 23. India Acne Medication, by Type USD Million (2017-2022)
  • Table 24. India Acne Medication, by Application USD Million (2017-2022)
  • Table 25. South Korea Acne Medication, by Type USD Million (2017-2022)
  • Table 26. South Korea Acne Medication, by Application USD Million (2017-2022)
  • Table 27. Taiwan Acne Medication, by Type USD Million (2017-2022)
  • Table 28. Taiwan Acne Medication, by Application USD Million (2017-2022)
  • Table 29. Australia Acne Medication, by Type USD Million (2017-2022)
  • Table 30. Australia Acne Medication, by Application USD Million (2017-2022)
  • Table 31. Rest of Asia-Pacific Acne Medication, by Type USD Million (2017-2022)
  • Table 32. Rest of Asia-Pacific Acne Medication, by Application USD Million (2017-2022)
  • Table 33. Europe Acne Medication, by Country USD Million (2017-2022)
  • Table 34. Europe Acne Medication, by Type USD Million (2017-2022)
  • Table 35. Europe Acne Medication, by Application USD Million (2017-2022)
  • Table 36. Germany Acne Medication, by Type USD Million (2017-2022)
  • Table 37. Germany Acne Medication, by Application USD Million (2017-2022)
  • Table 38. France Acne Medication, by Type USD Million (2017-2022)
  • Table 39. France Acne Medication, by Application USD Million (2017-2022)
  • Table 40. Italy Acne Medication, by Type USD Million (2017-2022)
  • Table 41. Italy Acne Medication, by Application USD Million (2017-2022)
  • Table 42. United Kingdom Acne Medication, by Type USD Million (2017-2022)
  • Table 43. United Kingdom Acne Medication, by Application USD Million (2017-2022)
  • Table 44. Netherlands Acne Medication, by Type USD Million (2017-2022)
  • Table 45. Netherlands Acne Medication, by Application USD Million (2017-2022)
  • Table 46. Rest of Europe Acne Medication, by Type USD Million (2017-2022)
  • Table 47. Rest of Europe Acne Medication, by Application USD Million (2017-2022)
  • Table 48. MEA Acne Medication, by Country USD Million (2017-2022)
  • Table 49. MEA Acne Medication, by Type USD Million (2017-2022)
  • Table 50. MEA Acne Medication, by Application USD Million (2017-2022)
  • Table 51. Middle East Acne Medication, by Type USD Million (2017-2022)
  • Table 52. Middle East Acne Medication, by Application USD Million (2017-2022)
  • Table 53. Africa Acne Medication, by Type USD Million (2017-2022)
  • Table 54. Africa Acne Medication, by Application USD Million (2017-2022)
  • Table 55. North America Acne Medication, by Country USD Million (2017-2022)
  • Table 56. North America Acne Medication, by Type USD Million (2017-2022)
  • Table 57. North America Acne Medication, by Application USD Million (2017-2022)
  • Table 58. United States Acne Medication, by Type USD Million (2017-2022)
  • Table 59. United States Acne Medication, by Application USD Million (2017-2022)
  • Table 60. Canada Acne Medication, by Type USD Million (2017-2022)
  • Table 61. Canada Acne Medication, by Application USD Million (2017-2022)
  • Table 62. Mexico Acne Medication, by Type USD Million (2017-2022)
  • Table 63. Mexico Acne Medication, by Application USD Million (2017-2022)
  • Table 64. Acne Medication: by Type(USD/Units)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Acne Medication: by Type(USD Million)
  • Table 75. Acne Medication Injection , by Region USD Million (2023-2028)
  • Table 76. Acne Medication Oral , by Region USD Million (2023-2028)
  • Table 77. Acne Medication: by Application(USD Million)
  • Table 78. Acne Medication Hospital , by Region USD Million (2023-2028)
  • Table 79. Acne Medication Clinic , by Region USD Million (2023-2028)
  • Table 80. South America Acne Medication, by Country USD Million (2023-2028)
  • Table 81. South America Acne Medication, by Type USD Million (2023-2028)
  • Table 82. South America Acne Medication, by Application USD Million (2023-2028)
  • Table 83. Brazil Acne Medication, by Type USD Million (2023-2028)
  • Table 84. Brazil Acne Medication, by Application USD Million (2023-2028)
  • Table 85. Argentina Acne Medication, by Type USD Million (2023-2028)
  • Table 86. Argentina Acne Medication, by Application USD Million (2023-2028)
  • Table 87. Rest of South America Acne Medication, by Type USD Million (2023-2028)
  • Table 88. Rest of South America Acne Medication, by Application USD Million (2023-2028)
  • Table 89. Asia Pacific Acne Medication, by Country USD Million (2023-2028)
  • Table 90. Asia Pacific Acne Medication, by Type USD Million (2023-2028)
  • Table 91. Asia Pacific Acne Medication, by Application USD Million (2023-2028)
  • Table 92. China Acne Medication, by Type USD Million (2023-2028)
  • Table 93. China Acne Medication, by Application USD Million (2023-2028)
  • Table 94. Japan Acne Medication, by Type USD Million (2023-2028)
  • Table 95. Japan Acne Medication, by Application USD Million (2023-2028)
  • Table 96. India Acne Medication, by Type USD Million (2023-2028)
  • Table 97. India Acne Medication, by Application USD Million (2023-2028)
  • Table 98. South Korea Acne Medication, by Type USD Million (2023-2028)
  • Table 99. South Korea Acne Medication, by Application USD Million (2023-2028)
  • Table 100. Taiwan Acne Medication, by Type USD Million (2023-2028)
  • Table 101. Taiwan Acne Medication, by Application USD Million (2023-2028)
  • Table 102. Australia Acne Medication, by Type USD Million (2023-2028)
  • Table 103. Australia Acne Medication, by Application USD Million (2023-2028)
  • Table 104. Rest of Asia-Pacific Acne Medication, by Type USD Million (2023-2028)
  • Table 105. Rest of Asia-Pacific Acne Medication, by Application USD Million (2023-2028)
  • Table 106. Europe Acne Medication, by Country USD Million (2023-2028)
  • Table 107. Europe Acne Medication, by Type USD Million (2023-2028)
  • Table 108. Europe Acne Medication, by Application USD Million (2023-2028)
  • Table 109. Germany Acne Medication, by Type USD Million (2023-2028)
  • Table 110. Germany Acne Medication, by Application USD Million (2023-2028)
  • Table 111. France Acne Medication, by Type USD Million (2023-2028)
  • Table 112. France Acne Medication, by Application USD Million (2023-2028)
  • Table 113. Italy Acne Medication, by Type USD Million (2023-2028)
  • Table 114. Italy Acne Medication, by Application USD Million (2023-2028)
  • Table 115. United Kingdom Acne Medication, by Type USD Million (2023-2028)
  • Table 116. United Kingdom Acne Medication, by Application USD Million (2023-2028)
  • Table 117. Netherlands Acne Medication, by Type USD Million (2023-2028)
  • Table 118. Netherlands Acne Medication, by Application USD Million (2023-2028)
  • Table 119. Rest of Europe Acne Medication, by Type USD Million (2023-2028)
  • Table 120. Rest of Europe Acne Medication, by Application USD Million (2023-2028)
  • Table 121. MEA Acne Medication, by Country USD Million (2023-2028)
  • Table 122. MEA Acne Medication, by Type USD Million (2023-2028)
  • Table 123. MEA Acne Medication, by Application USD Million (2023-2028)
  • Table 124. Middle East Acne Medication, by Type USD Million (2023-2028)
  • Table 125. Middle East Acne Medication, by Application USD Million (2023-2028)
  • Table 126. Africa Acne Medication, by Type USD Million (2023-2028)
  • Table 127. Africa Acne Medication, by Application USD Million (2023-2028)
  • Table 128. North America Acne Medication, by Country USD Million (2023-2028)
  • Table 129. North America Acne Medication, by Type USD Million (2023-2028)
  • Table 130. North America Acne Medication, by Application USD Million (2023-2028)
  • Table 131. United States Acne Medication, by Type USD Million (2023-2028)
  • Table 132. United States Acne Medication, by Application USD Million (2023-2028)
  • Table 133. Canada Acne Medication, by Type USD Million (2023-2028)
  • Table 134. Canada Acne Medication, by Application USD Million (2023-2028)
  • Table 135. Mexico Acne Medication, by Type USD Million (2023-2028)
  • Table 136. Mexico Acne Medication, by Application USD Million (2023-2028)
  • Table 137. Acne Medication: by Type(USD/Units)
  • Table 138. Research Programs/Design for This Report
  • Table 139. Key Data Information from Secondary Sources
  • Table 140. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Acne Medication: by Type USD Million (2017-2022)
  • Figure 5. Global Acne Medication: by Application USD Million (2017-2022)
  • Figure 6. South America Acne Medication Share (%), by Country
  • Figure 7. Asia Pacific Acne Medication Share (%), by Country
  • Figure 8. Europe Acne Medication Share (%), by Country
  • Figure 9. MEA Acne Medication Share (%), by Country
  • Figure 10. North America Acne Medication Share (%), by Country
  • Figure 11. Global Acne Medication: by Type USD/Units (2017-2022)
  • Figure 12. Global Acne Medication share by Players 2022 (%)
  • Figure 13. Global Acne Medication share by Players (Top 3) 2022(%)
  • Figure 14. Global Acne Medication share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Allergan plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 17. Allergan plc (Ireland) Revenue: by Geography 2022
  • Figure 18. Galderma S.A. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 19. Galderma S.A. (Switzerland) Revenue: by Geography 2022
  • Figure 20. LG Chem. (South Korea) Revenue, Net Income and Gross profit
  • Figure 21. LG Chem. (South Korea) Revenue: by Geography 2022
  • Figure 22. BohusBioTech AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 23. BohusBioTech AB (Sweden) Revenue: by Geography 2022
  • Figure 24. Imeik Technology Development Co Ltd (China) Revenue, Net Income and Gross profit
  • Figure 25. Imeik Technology Development Co Ltd (China) Revenue: by Geography 2022
  • Figure 26. Bloomage Freda Biopharm Co. LTD (China) Revenue, Net Income and Gross profit
  • Figure 27. Bloomage Freda Biopharm Co. LTD (China) Revenue: by Geography 2022
  • Figure 28. Sinclair Pharma Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Sinclair Pharma Plc (United Kingdom) Revenue: by Geography 2022
  • Figure 30. Merz Pharma GmbH & Co. KGaA (Germany) Sanofi Aventis (France) Revenue, Net Income and Gross profit
  • Figure 31. Merz Pharma GmbH & Co. KGaA (Germany) Sanofi Aventis (France) Revenue: by Geography 2022
  • Figure 32. Suneva Medical (United States) Revenue, Net Income and Gross profit
  • Figure 33. Suneva Medical (United States) Revenue: by Geography 2022
  • Figure 34. Global Acne Medication: by Type USD Million (2023-2028)
  • Figure 35. Global Acne Medication: by Application USD Million (2023-2028)
  • Figure 36. South America Acne Medication Share (%), by Country
  • Figure 37. Asia Pacific Acne Medication Share (%), by Country
  • Figure 38. Europe Acne Medication Share (%), by Country
  • Figure 39. MEA Acne Medication Share (%), by Country
  • Figure 40. North America Acne Medication Share (%), by Country
  • Figure 41. Global Acne Medication: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Allergan plc (Ireland)
  • Galderma S.A. (Switzerland)
  • LG Chem. (South Korea)
  • BohusBioTech AB (Sweden)
  • Imeik Technology Development Co Ltd (China)
  • Bloomage Freda Biopharm Co. LTD (China)
  • Sinclair Pharma Plc (United Kingdom)
  • Merz Pharma GmbH & Co. KGaA (Germany) Sanofi Aventis (France)
  • Suneva Medical (United States)
Additional players considered in the study are as follows:
Stiefel (United States) , Valeant (Canada) , Bayer HealthCare (Germany)
Select User Access Type

Key Highlights of Report


Nov 2023 203 Pages 76 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Acne Medication Market Quantitative research analysis
Global Acne Medication Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Acne Medication study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Acne Medication Market is gaining popularity and expected to see strong valuation by 2028 and may reach USD 11654.0 Million .
According to AMA, the Global Acne Medication market is expected to see growth rate of xx%.
The Acne Medication market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Acne Medication Market Report?

Have a Query? Click Here

Other Related Reports

Betamethasone Ointment Comprehensive Study by Type (Betamethasone Dipropionate, Betamethasone Sodium Phosphate, Betamethasone Valerate), Application (Eczema, Dermatitis, Allergies, Rash), Distributio...
$ 3450
Sulfachloropyridazine Sodium Comprehensive Study by Type (Concentration: <10% , Concentration: 10%-20%), Application (Escherichia Coli Infection Treatment , Staphylococcal Infection Treatment), Route...
$ 3750
Clozapine Comprehensive Study by Application (Hospital, Clinic, Home Care), Distribution Channel (Online Retail, Offline Retail), Form (Tablet, Liquid) Players and Region - Global Market Outlook to ...
$ 3500
Compounding Pharmacy Comprehensive Study by Type (Oral (Capsules, Tablets, suspensions, lozenges, lollipops), Topical (Cream, gel, ointments, lotions), Mouthwashes, Suppositories, Injectables (Inject...
$ 3750
Antiemetic Drugs Comprehensive Study by Type (Dopamine Antagonist, 5-HT-3 Receptor Antagonist, NK1 Receptor Antagonist, Cannabinoid Receptor Antagonist), Application (Chemotherapy, Gastroenteritis, S...
$ 3450
Antipsychotic Drugs Comprehensive Study by Type (First Antipsychotic Drugs (Typical Antipsychotics), Second Antipsychotic Drugs (Newer Drugs), Third Antipsychotic Drugs), Application (Schizophrenia, ...
$ 3650